These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

117 related items for PubMed ID: 552102

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Protective effects of a combination thromboxane synthesis inhibitor-receptor antagonist, R-68070, during murine traumatic shock.
    Aoki N, Johnson G, Siegfried MR, Lefer AM.
    Eicosanoids; 1989; 2(3):169-74. PubMed ID: 2534278
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Protective effects of KW-3635, a novel thromboxane A2 antagonist, in murine traumatic shock.
    Karasawa A, Taylor PA, Lefer AM.
    Eur J Pharmacol; 1990 Jun 21; 182(1):1-8. PubMed ID: 2401310
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Beneficial effects of BAY u3405, a novel thromboxane A2 receptor antagonist, in splanchnic artery occlusion shock.
    Canale P, Squadrito F, Altavilla D, Ioculano M, Campo GM, Squadrito G, Urna G, Sardella A, Caputi AP.
    Pharmacology; 1994 Dec 21; 49(6):376-85. PubMed ID: 7878075
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Beneficial effects of a neutral protease inhibitor in traumatic shock.
    Hock CE, Lefer AM.
    Pharmacol Res Commun; 1985 Mar 21; 17(3):217-26. PubMed ID: 4011646
    [Abstract] [Full Text] [Related]

  • 19. Synthesis and biological properties of pinane-thromboxane A2, a selective inhibitor of coronary artery constriction, platelet aggregation, and thromboxane formation.
    Nicolaou KC, Magolda RL, Smith JB, Aharony D, Smith EF, Lefer AM.
    Proc Natl Acad Sci U S A; 1979 Jun 21; 76(6):2566-70. PubMed ID: 288046
    [Abstract] [Full Text] [Related]

  • 20. Glucocorticoid induced protection in experimental traumatic shock.
    Sollott SJ, Galvin MJ, Lefer AM.
    Proc Soc Exp Biol Med; 1979 Mar 21; 160(3):317-20. PubMed ID: 432240
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.